Management and 1-year outcomes of patients with atrial fibrillation in the Middle East: Gulf survey of atrial fibrillation events
Affiliations
Affiliations
- Department of Medicine, Faculty of Medicine, Kuwait University, Safat, Kuwait zubaid@hsc.edu.kw.
- Department of Medicine, Mubarak Al-Kabeer Hospital, Ministry of Health, Jabriya, Kuwait.
- Heart and Vascular Institute, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates Department of Medicine, Tufts Clinical and Translational Science Institute, Tufts Medical Center and Tufts University School of Medicine, Boston, MA, USA.
- Department of Pharmacology & Clinical Pharmacy, College of Medicine & Health Sciences, Sultan Qaboos University, Muscat, Oman Gulf Health Research, Muscat, Oman.
- Heart and Vascular Institute, Sheikh Khalifa Medical City, Abu Dhabi, United Arab Emirates.
- Department of Medicine, Faculty of Medicine, UAE University, Al-Ain, United Arab Emirates.
- Department of Medicine, Royal Hospital, Muscat, Oman.
- Department of Medicine, Al Thawra Hospital, Sana'a, Yemen.
- Department of Cardiology and Cardiovascular Surgery, Hamad Medical Corporation, Doha, Qatar.
- Department of Cardiology, Mohammed Bin Khalifa Cardiac Centre, Manama, Bahrain.
Abstract
We describe management and outcomes of patients with nonvalvular atrial fibrillation (AF) in the Middle East. Consecutive patients with AF presenting to emergency departments (EDs) were prospectively enrolled. Among 1721 patients with nonvalvular AF, mean age was 59 ± 16 years and 44% were women. Comorbidities were common such as hypertension (59%), diabetes (33%), and coronary artery disease (33%). Warfarin was not prescribed to 40% of patients with Congestive heart failure, Hypertension, Age, Diabetes mellitus, Stroke/TIA2 score of ≥2. One-year rates of stroke/transient ischemic attack (TIA) and all-cause mortality were 4.2% and 15.3%, respectively. Warfarin use at hospital-ED discharge was independently associated with lower 1-year rate of stroke/TIA (odds ratio [OR], 0.38; 95% confidence interval [CI], 0.17-0.85; P = .015) and all-cause mortality (OR, 0.51; 95% CI, 0.32-0.83; P = .006). Prior history of heart failure and peripheral vascular disease was independent mortality predictors. Our patients are relatively young with significant cardiovascular risk. Their anticoagulation treatment is suboptimal, and 1-year all-cause mortality and stroke/TIA event rates are relatively high.
Keywords: Middle East; anticoagulation; atrial fibrillation; risk assessment; stroke.
Similar articles
Wang C, Yang Z, Wang C, Wang Y, Zhao X, Liu L, Wang DZ, Li H, Wang Y.J Stroke Cerebrovasc Dis. 2014 May-Jun;23(5):1157-63. doi: 10.1016/j.jstrokecerebrovasdis.2013.10.006. Epub 2013 Dec 2.PMID: 24291013
Quality of care for atrial fibrillation among patients hospitalized for heart failure.
Piccini JP, Hernandez AF, Zhao X, Patel MR, Lewis WR, Peterson ED, Fonarow GC; Get With The Guidelines Steering Committee and Hospitals.J Am Coll Cardiol. 2009 Sep 29;54(14):1280-9. doi: 10.1016/j.jacc.2009.04.091.PMID: 19778670
'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey.
Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH, Ioachim PM, Tica O, Boriani G, Cimaglia P, Diemberger I, Hellum CF, Mortensen B, Maggioni AP.Am J Med. 2014 Jun;127(6):519-29.e1. doi: 10.1016/j.amjmed.2013.12.022. Epub 2014 Jan 28.PMID: 24486284
[Atrial fibrillation and thromboembolic events prevention. State of the art].
Matteoli S, Trappolini M, Chillotti FM.Minerva Cardioangiol. 2001 Feb;49(1):1-13.PMID: 11279381 Review. Italian.
Independent predictors of stroke in patients with atrial fibrillation: a systematic review.
Stroke Risk in Atrial Fibrillation Working Group.Neurology. 2007 Aug 7;69(6):546-54. doi: 10.1212/01.wnl.0000267275.68538.8d.PMID: 17679673 Review.
Cited by
Hammoudeh A, Khader Y, Tabbalat R, Badaineh Y, Kadri N, Shawer H, Al-Mousa E, Ibdah R, Shawer BA, Alhaddad IA.Int J Vasc Med. 2022 Apr 13;2022:4240999. doi: 10.1155/2022/4240999. eCollection 2022.PMID: 35462945 Free PMC article.
Rivaroxaban Experience at Tertiary Care Centre in Saudi Arabia:A Retrospective Observational Study.
Riazuddin M, Mpharm MA, Butt MI, Abufarhaneh M, Masud Khan S, Emadi O, AlKasab MS, Fahad Alsudairy H, AlShammari K, Sheikh A, AlRashed A.Galen Med J. 2020 Dec 26;9:e1882. doi: 10.31661/gmj.v9i0.1882. eCollection 2020.PMID: 34466605 Free PMC article.
Hersi AS, Alhebaishi YS, Hamoui O, Hassan T, Khalifa Hamad A, Magdy M, Sabbour H, Shaheen S.J Saudi Heart Assoc. 2018 Apr;30(2):122-139. doi: 10.1016/j.jsha.2017.05.001. Epub 2017 Jun 8.PMID: 29910583 Free PMC article. Review.
Liu FD, Zhao R, Wang XM, Wang S, Shen XL, Tao XX, Zheng B, Peng JL, Zhang H, Mo R, Tong Y, Li WT, Feng XY, Li GF, Shu L, Liu JR.Chronic Dis Transl Med. 2016 Jan 8;1(4):203-209. doi: 10.1016/j.cdtm.2015.11.005. eCollection 2015 Dec.PMID: 29063008 Free PMC article.
Zubaid M, Rashed W, Alsheikh-Ali AA, Garadah T, Alrawahi N, Ridha M, Akbar M, Alenezi F, Alhamdan R, Almahmeed W, Ouda H, Al-Mulla A, Baslaib F, Shehab A, Alnuaimi A, Amin H.Heart Views. 2017 Apr-Jun;18(2):41-46. doi: 10.4103/HEARTVIEWS.HEARTVIEWS_113_16.PMID: 28706594 Free PMC article.